Alisa Lask - 01 Jan 2025 Form 4 Insider Report for NEPHROS INC (NEPH)

Reporting relationship: Director
Issuer ticker: NEPH
Reported as of: 01 Jan 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 03 Jan 2025, 17:08:03 UTC
Prior SEC filing: 16 May 2024
Next SEC filing: 18 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Christopher Melsha as attorney-in-fact for Alisa Lask pursuant to power of attorney previously filed.

Key filing fact

Alisa Lask filed Form 4 for NEPHROS INC (NEPH) on 03 Jan 2025.

Key facts

This page summarizes Alisa Lask's Form 4 filing for NEPHROS INC (NEPH).
1 reported transaction and 7 derivative rows are listed below.
Accepted by SEC: 03 Jan 2025, 17:08.

Change

Previous filing in this sequence was filed on 16 May 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NEPH holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 48,629
Date: 01 Jan 2025
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NEPH transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +7,050
Change %
Price: $0.000000
Shares after: 7,050
Date: 01 Jan 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 7,050
Exercise price: $1.47
Footnotes: F4

NEPH holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 9,617
Date: 01 Jan 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 9,617
Exercise price: $5.22
Footnotes: F1

NEPH holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 5,568
Date: 01 Jan 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 5,568
Exercise price: $8.57
Footnotes: F1

NEPH holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 6,850
Date: 01 Jan 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 6,850
Exercise price: $8.06
Footnotes: F1

NEPH holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 7,062
Date: 01 Jan 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 7,062
Exercise price: $6.82
Footnotes: F1

NEPH holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 7,080
Date: 01 Jan 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 7,080
Exercise price: $1.07
Footnotes: F2

NEPH holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 7,323
Date: 01 Jan 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 7,323
Exercise price: $2.14
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Fully exercisable.

Footnote F2

This option vests as to 2,360 shares on each of 1/5/23, 1/5/24 and 1/5/25.

Footnote F3

This option vests as to 2,441 shares on each of 5/14/24, 5/14/25 and 5/14/26.

Footnote F4

Represents options granted to the reporting person for her service on the Company's Board of Directors for 2024. This option vests as to 2,350 shares on each of 1/1/25, 1/1/26 and 1/1/27.